Molecular Partners AG
MOLN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001745114
No open-market purchases or sales by Molecular Partners AG insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Molecular Partners AG changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 4 | 5 | +1 |
| Shares | 3.59M | 3.59M | +1.92K (+0.1%) |
| Value | $14.2M | $13.8M | −$431.9K (−3.0%) |
New holders (2)
Institutions that held Molecular Partners AG at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 17,179 | $65.3K | 0.00% |
| UBS Group AG | 279 | $1.08K | 0.00% |
Sold out (1)
Institutions that held Molecular Partners AG at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| SmartHarvest Portfolios, LLC | 15,543 | $61.7K |